Literature DB >> 16281945

Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate.

Simon Jones1, Edward R Duncan, Nikki Thomas, Joan Walters, Moira C Dick, Susan E Height, Adrian D Stephens, Swee Lay Thein, David C Rees.   

Abstract

Sickle cell disease (SCD) is characterised by intermittent episodes of acute severe pain, related to vaso-occlusion. Environmental factors are thought to play an important role, and studies in tropical countries have suggested that cold and rainy seasons are associated with increased episodes of acute pain. We have studied retrospectively the number of admissions with acute pain and SCD to King's College Hospital, London, together with daily meteorological records collected locally. Data from 1400 d and 1047 separate admissions were analysed. Increased admissions were significantly associated with increased wind speed and low humidity, but showed no relationship to temperature, rainfall or barometric pressure. The strongest effect was for (maximum wind speed)/humidity, with 464 admissions on days in the lowest two quartiles of this parameter and 582 in the highest quartiles. The effect of high wind and low humidity is likely to be related to skin cooling.

Entities:  

Mesh:

Year:  2005        PMID: 16281945     DOI: 10.1111/j.1365-2141.2005.05799.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  23 in total

Review 1.  Environmental determinants of severity in sickle cell disease.

Authors:  Sanjay Tewari; Valentine Brousse; Frédéric B Piel; Stephan Menzel; David C Rees
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

Review 2.  Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease.

Authors:  Katelyn E Sadler; Cheryl L Stucky
Journal:  Neurosci Lett       Date:  2018-11-30       Impact factor: 3.046

Review 3.  Measuring success: utility of biomarkers in sickle cell disease clinical trials and care.

Authors:  Ram Kalpatthi; Enrico M Novelli
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

Authors:  Cheryl A Hillery; Patrick C Kerstein; Daniel Vilceanu; Marie E Barabas; Dawn Retherford; Amanda M Brandow; Nancy J Wandersee; Cheryl L Stucky
Journal:  Blood       Date:  2011-06-27       Impact factor: 22.113

Review 5.  Management of sickle cell disease in the community.

Authors:  Valentine Brousse; Julie Makani; David C Rees
Journal:  BMJ       Date:  2014-03-10

6.  Presence of neuropathic pain as an underlying mechanism for pain associated with cold weather in patients with sickle cell disease.

Authors:  R E Molokie; Z J Wang; D J Wilkie
Journal:  Med Hypotheses       Date:  2011-07-16       Impact factor: 1.538

Review 7.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

8.  Ambient air pollution and sickle cell disease-related emergency department visits in Atlanta, GA.

Authors:  Amelia H Blumberg; Stefanie T Ebelt; Donghai Liang; Claudia R Morris; Jeremy A Sarnat
Journal:  Environ Res       Date:  2020-02-27       Impact factor: 6.498

9.  Opioid Prescription Filling Trends Among Children with Sickle Cell Disease After the Release of State-Issued Guidelines on Pain Management.

Authors:  Susan E Creary; Deena J Chisolm; Sharon K Wrona; Jennifer N Cooper
Journal:  Pain Med       Date:  2020-10-01       Impact factor: 3.750

10.  Association between wind speed and the occurrence of sickle cell acute painful episodes: results of a case-crossover study.

Authors:  Vikki G Nolan; Yuqing Zhang; Timothy Lash; Paola Sebastiani; Martin H Steinberg
Journal:  Br J Haematol       Date:  2008-08-20       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.